Heerma Peter
SEC insider (Form 3/4/5 filer). CIK 0001789617. EVP, CHIEF COMMERCIAL OFFICER at Travere Therapeutics, Inc. (TVTX). 36 reported Form 4/5 transactions since Sep 2024; latest on Sep 17, 2026. Located in SAN DIEGO, CA.
Companies Heerma Peter has filed insider reports for
- Travere Therapeutics, Inc. (TVTX): Officer, EVP, CHIEF COMMERCIAL OFFICER
Heerma Peter
CIK: 0001789617
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Travere Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (36 total)
- Sep 17, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect8.3K shares at avg. $22.40$186K - Sep 17, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect8.3K shares at avg. $65.07$539K - Sep 16, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect17.7K shares at avg. $26.88$476K - Sep 16, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect79.1K shares at avg. $63.65$5.0M - Sep 16, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect55K shares at avg. $15.46$850K - Sep 16, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect100K shares at avg. $11.25$1.1M - Sep 16, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect93.6K shares at avg. $63.25$5.9M - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect71.9K shares at avg. $62.05$4.5M - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect39.3K shares at avg. $26.88$1.1M - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect1.4K shares at avg. $22.40$31K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 17, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 8,282 | $22.40 | $185,517 | Direct |
| Sep 17, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 8,282 | $65.07 | $538,917 | Direct |
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 17,717 | $26.88 | $476,233 | Direct |
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 79,113 | $63.65 | $5,035,906 | Direct |
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 55,000 | $15.46 | $850,300 | Direct |
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 100,000 | $11.25 | $1,125,000 | Direct |
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 93,604 | $63.25 | $5,920,182 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 71,938 | $62.05 | $4,463,875 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 39,283 | $26.88 | $1,055,927 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 1,381 | $22.40 | $30,934 | Direct |
1-10 of 36 transactions